Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02513056 · ClinicalTrials.gov registry record
Study Evaluating the Use of MRI on CMS Patients
A clinical trial, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 872
- Enrollment target
NCT02513056: Completed study, sponsored by University of Pennsylvania.
NCT02513056 is a clinical trial that has completed, run by University of Pennsylvania. The registered enrollment target is 872 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02513056 has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 872 participants
- Enrollment target
Study Summary
The overall objective of this protocol is to evaluate the safety and utility of diagnostic MRI in Center for Medicare and Medicaid Services (CMS) beneficiaries with pacemakers and Implantable Cardioverter Defibrillators (ICD) and clinical need for MRI.
Primary Outcome
The primary measure of this study is physician decision making. Referring physicians will be asked about the effect of the MRI clinical management strategy, planning of treatments and interventions, as well as if/how the MRI results prevented other diagnostic studies or interventions, and other exposures (such as to ionizing radiation or iodinated contrast from CT scans). Analysis will be tabulation of how scan would change treatment or prognosis and what would be done if MR not available (based
Interventions
- OTHER MRI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 872 participants |
| Start Date | 2015-08-17 |
| Est. Completion | 2022-02-01 |
What the finished NCT02513056 record still lists
NCT02513056 is an observational study that tracks outcomes without assigning an intervention. The registered 872 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which MRI is the first listed.
NCT02513056 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02513056 about?
NCT02513056 is a clinical study titled "Study Evaluating the Use of MRI on CMS Patients". The overall objective of this protocol is to evaluate the safety and utility of diagnostic MRI in Center for Medicare and Medicaid Services (CMS) beneficiaries with pacemakers and Implantable Cardioverter Defibrillators (ICD) and clinical need for MRI.
What is the current status of trial NCT02513056?
This trial is currently completed. The enrollment target is 872 participants. The study started on 2015-08-17. Estimated completion is 2022-02-01.
What interventions are being tested in trial NCT02513056?
The interventions under investigation include: MRI (OTHER).
Who is sponsoring clinical trial NCT02513056?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04097145 · 870 participants · NA
Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial
- NCT06822790 · 869 participants · Phase 3
Long-Term Safety and Efficacy of Plozasiran in Adults With Hypertriglyceridemia
- NCT06077760 · 868 participants · Phase 3
A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)
- NCT07076199 · 877 participants · Phase 3
A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine, Both in Combination With Insulin Aspart, in Adults With Type 1 Diabetes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI